No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Diabetes

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db06-1248PMID 17327427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4[+]CD25[+]Foxp3[+] T cells and CD4[+]CD25[-]Foxp3[+] T cells in aged mice

  2007cited by this paper
• IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

  2006cited by this paper
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

  2006cited by this paper
• Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

  2006cited by this paper
• Regulatory T cells in human disease and their potential for therapeutic manipulation

  2006cited by this paper
• CD4+CD25+Foxp3+ T Cells and CD4+CD25−Foxp3+ T Cells in Aged Mice1

  2006cited by this paper
• Are regulatory T-cells linked with aging?

  2006cited by this paper
• Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

  2006cited by this paper
• MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1

  2006cited by this paper
• Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.

  2006cited by this paper
• FOXP3: of mice and men.

  2006cited by this paper
• A function for interleukin 2 in Foxp3-expressing regulatory T cells

  2005cited by this paper
• Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

  2005cited by this paper
• Fueling regulation: IL-2 keeps CD4+ Treg cells fit

  2005cited by this paper
• CD4+CD25high regulatory T cells in human autoimmune diabetes.

  2005cited by this paper
• Type 1 diabetes genes and pathways shared by humans and NOD mice.

  2005cited by this paper
• Nonobese Diabetic Mouse Congenic Analysis Reveals Chromosome 11 Locus Contributing to Diabetes Susceptibility, Macrophage STAT5 Dysfunction, and Granulocyte-Macrophage Colony-Stimulating Factor Overproduction1

  2005cited by this paper
• Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.

  2005cited by this paper
• Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

  2005cited by this paper
• L‐selectin: mechanisms and physiological significance of ectodomain cleavage

  2005cited by this paper
• Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

  2005cited by this paper
• Regulatory T cells and type 1 diabetes

  2005cited by this paper
• Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

  2005cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• CD4+ T Cell Proliferation in Response to GAD and Proinsulin in Healthy, Pre‐diabetic, and Diabetic Donors

  2004cited by this paper
• Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

  2004cited by this paper
• Human CD4+CD25+ regulatory T cells.

  2004cited by this paper
• Molecular aspects of regulatory T cell development.

  2004cited by this paper
• A Mutant Stat5b with Weaker DNA Binding Affinity Defines a Key Defective Pathway in Nonobese Diabetic Mice*

  2004cited by this paper
• Autoimmune Diseases as the Loss of Active “Self‐Control”

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Functional assay for human CD4+CD25+ Treg cells reveals an age‐dependent loss of suppressive activity

  2003cited by this paper
• [Current concepts of autoimmunity].

  2002cited by this paper
• Multiple immuno-regulatory defects in type-1 diabetes.

  2002cited by this paper
• Interleukin-2 signaling and the maintenance of self-tolerance.

  2002cited by this paper
• Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

  2001cited by this paper
• Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping.

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• The NOD mouse model of type 1 diabetes: As good as it gets?

  1999cited by this paper
• Imbalance of the interleukin 2 system in children with IDDM

  1994cited by this paper
• Interleukin 2 and Soluble Interleukin 2–Receptor Secretion Defect In Vitro in Newly Diagnosed Type I Diabetic Patients

  1989cited by this paper
• Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes.

  1988cited by this paper

• Next steps in regulatory T cells: Biology and clinical application.

  2026cites this paper
• Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes

  2026cites this paper
• Targeting Tregs in T1DM: bridging heterogeneity, mechanisms, and clinical progress.

  2025cites this paper
• The role of ubiquitin ligases in regulating immune cell functions

  2025cites this paper
• Developmental Origin and Functional Diversity of Foxp3+ Regulatory T Cells in Diabetes and Obesity

  2025cites this paper
• The role of N-glycans in regulatory T cells in autoimmunity.

  2025cites this paper
• Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies

  2025cites this paper
• Imbalance of stem-like and effector T cell states in children with early type 1 diabetes across conventional and regulatory subsets

  2025cites this paper
• Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes

  2025cites this paper
• Shed light on molecular immunogenetic pathophysiology of type 1 diabetes to improve advanced treatment strategies.

  2025cites this paper
• Regulatory T Cell Dysfunction in Autoimmune Diseases

  2024cites this paper
• The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus.

  2024cites this paper
• Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes

  2024cites this paper
• Innovative Immunotherapies and Emerging Treatments in Type 1 Diabetes Management

  2024cites this paper
• The Increased Frequency of Type 1 Regulatory T (Tr1) Cells and the Altered Expression of Aryl Hydrocarbon Receptor (AHR) and Interferon Regulatory Factor-4 (IRF4) Genes in Type 1 Diabetes: A Case-Control Study

  2024cites this paper
• TGF-β-mediated crosstalk between TIGIT+ Tregs and CD226+CD8+ T cells in the progression and remission of type 1 diabetes

  2024cites this paper
• Autoimmune uveitis attenuated in diabetic mice through imbalance of Th1/Th17 differentiation via suppression of AP-1 signaling pathway in Th cells

  2024cites this paper
• PPARs at the crossroads of T cell differentiation and type 1 diabetes

  2023cites this paper
• Lentinan confers protection against type 1 diabetes by inducing regulatory T cell in spontaneous non-obese diabetic mice

  2023cites this paper
• T cells in health and disease

  2023cites this paper
• Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes

  2023cites this paper
• Translation of Cell Therapies to Treat Autoimmune Disorders.

  2023cites this paper
• Drivers of consumers’ behavioral intention toward private umbilical cord blood banking: a review

  2022cites this paper
• Screening of key genes associated with m6A methylation in diabetic nephropathy patients by CIBERSORT and weighted gene coexpression network analysis.

  2022cites this paper
• Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

  2022cites this paper
• Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes

  2022cites this paper
• Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T cells

  2022cites this paper
• Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD RhapsodyTM VDJ CDR3 Assay

  2022cites this paper
• Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study

  2022cites this paper
• Negative Regulation of FOXP3 Expression by c-Rel O-GlcNAcylation.

  2021cites this paper
• Improving the Efficacy of Regulatory T Cell Therapy

  2021cites this paper
• The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes

  2021cites this paper
• The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients

  2021cites this paper
• Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.

  2021cites this paper
• Study of Regulatory T-cells in Type 1 Diabetes

  2021cites this paper
• Evolving Antibody Therapies for the Treatment of Type 1 Diabetes

  2021cites this paper
• CD4 CD25 T Cells in Children with Recent Onset Type 1 Diabetes

  2021cites this paper
• A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.

  2021cites this paper
• Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes

  2021cites this paper
• A reply to "TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes".

  2021cites this paper
• Abnormal Cannabidiol protects pancreatic beta cells in mouse models of experimental Type 1 diabetes

  2020cites this paper
• The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics

  2020cites this paper
• Latent autoimmune diabetes in adults (LADA)

  2020cites this paper
• Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation.

  2020cites this paper
• ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases

  2020cites this paper
• Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes

  2020cites this paper
• Redox Regulation of Tolerogenic Dendritic Cells and Regulatory T Cells in the Pathogenesis and Therapy of Autoimmunity

  2020cites this paper
• Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?

  2020cites this paper
• Metabolic adaptation orchestrates tissue context‐dependent behavior in regulatory T cells

  2020cites this paper
• Oral therapy with colonization factor antigen I prevents development of type 1 diabetes in Non-obese Diabetic mice

  2020cites this paper
• The progress and prospect of regulatory T cells in autoimmune diseases.

  2020cites this paper
• Increased islet antigen–specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes–protective haplotype

  2020cites this paper
• A modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling

  2020influential citation
• Vitamin D’s Effect on Immune Function

  2020cites this paper
• Reduced PD-1 expression on circulating CXCR5+ and CXCR5- FOXP3+ Treg cells marks type 1 diabetes initiation in children.

  2019cites this paper
• High Thymic Output of Effector CD4+ Cells May Lead to a Treg : T Effector Imbalance in the Periphery in NOD Mice

  2019cites this paper
• Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice

  2019cites this paper
• Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes

  2019cites this paper
• Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes

  2019cites this paper
• Does control of glycemia regulate immunological parameters in insulin-treated persons with type 1 diabetes?

  2019cites this paper
• Chronic Hepatitis C Infection Has No Effect on Peripheral CD4+CD25+ Tregulatory Cells in Patients with End-Stage Renal Disease

  2019cites this paper
• Characterization of proinsulin‐specific regulatory T cells in type 1 diabetes at different ages of onset

  2019cites this paper
• Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

  2019cites this paper
• FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children

  2019cites this paper
• Dietary Cows’ Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice

  2018cites this paper
• Challenges to Reshape the Future of Type 1 Diabetes Research.

  2018cites this paper
• T Cell Metabolism in Autoimmune Diseases

  2018cites this paper
• Prävention von Typ-1-Diabetes

  2018cites this paper
• Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study

  2018cites this paper
• Harnessing the power of regulatory T‐cells to control autoimmune diabetes: overview and perspective

  2018cites this paper
• A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum

  2017cites this paper
• Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response

  2017cites this paper
• Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells

  2017cites this paper
• Regulatory T cells in type 1 diabetes: the role of IL-35 in counteracting the disease

  2017cites this paper
• Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression

  2017cites this paper
• T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease.

  2017cites this paper
• Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes

  2017cites this paper
• Modeling the IL-2-Related Risk in Type One Diabetes by Selectively Lowering IL-2R Signaling in T Lymphocytes in NOD Mice

  2017cites this paper
• Latent autoimmune diabetes in adults (LADA)

  2017cites this paper
• Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?

  2017cites this paper
• The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease.

  2017cites this paper
• J Endocrinol 2017, 1(2): 000107

  2017cites this paper
• Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice

  2016cites this paper
• Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children

  2016cites this paper
• T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients

  2016cites this paper
• Mechanisms of autoimmunity in the non‐obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation

  2016cites this paper
• Restoring Regulatory T Cells in Type 1 Diabetes

  2016cites this paper
• Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

  2016cites this paper
• Estudio de terapias antígeno-específicas para la prevención de la diabetes tipo 1 en el ratón nod

  2016cites this paper
• Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA)

  2016cites this paper
• Regulatory T Cells in Type 1 Diabetes Mellitus

  2016cites this paper
• Cellular Immunological Mechanisms Contributing to Diabetes Pathogenesis

  2016cites this paper
• Factors influencing regulatory T cell maintenance for the control of autoimmunity

  2016cites this paper
• Regulatory T Cells: Translational Immunology: Mechanisms and Pharmacologic Approaches

  2016cites this paper
• Induction of antigen-specific tolerance and development of autoreactive T cells in an experimental model of autoimmune diabetes

  2016cites this paper
• Tregs and kidney: From diabetic nephropathy to renal transplantation

  2016cites this paper
• Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome

  2015cites this paper
• Regulatory T Cells in Autoimmune Diabetes: Mechanisms of Action and Translational Potential.

  2015cites this paper
• Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus

  2015cites this paper
• Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.

  2015cites this paper